Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
47,601,550
-
Total 13F shares
-
34,772,388
-
Share change
-
+1,267,435
-
Total reported value
-
$229,436,154
-
Put/Call ratio
-
38%
-
Price per share
-
$6.60
-
Number of holders
-
31
-
Value change
-
+$13,901,733
-
Number of buys
-
13
-
Number of sells
-
15
Institutional Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q4 2023
As of 31 Dec 2023,
ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,772,388 shares.
The largest 10 holders included
BVF INC/IL, Bellevue Group AG, Soleus Capital Management, L.P., MORGAN STANLEY, PFM Health Sciences, LP, RTW INVESTMENTS, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., JANUS HENDERSON GROUP PLC, Rock Springs Capital Management LP, and Rhenman & Partners Asset Management AB.
This page lists
31
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.